Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 39

Results For "infection"

598 News Found

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech
interviews | April 22, 2022

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech

Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans


USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial
Biotech | April 22, 2022

USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial

The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic


Qvella FAST System and FAST-PBC get CE marked and USFDA listed
Biotech | April 22, 2022

Qvella FAST System and FAST-PBC get CE marked and USFDA listed

With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods


SoftBank Robotics takes a five per cent stake in Avalon SteriTech
Digitisation | April 20, 2022

SoftBank Robotics takes a five per cent stake in Avalon SteriTech

Strive to empower public health with disinfection robotics solutions in post-pandemic era


Plasma-based green disinfectants can limit spread of infectious diseases like Covid-19
News | April 20, 2022

Plasma-based green disinfectants can limit spread of infectious diseases like Covid-19

Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19


SNIPR BIOME initiates first-in-human clinical trial with SNIPR001
Biotech | April 20, 2022

SNIPR BIOME initiates first-in-human clinical trial with SNIPR001

The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut


Albumedix and Valneva expand collaboration to include newly approved inactivated Covid-19 vaccine
Biotech | April 18, 2022

Albumedix and Valneva expand collaboration to include newly approved inactivated Covid-19 vaccine

This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines


Zydus Lifesciences receives final approval from USFDA for Cyanocobalamin Injection
Drug Approval | April 18, 2022

Zydus Lifesciences receives final approval from USFDA for Cyanocobalamin Injection

The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat


Wockhardt Hospital launch support group for Parkinson patients and families
Healthcare | April 15, 2022

Wockhardt Hospital launch support group for Parkinson patients and families

Parkinson’s is not limited to old people, even youngsters can suffer from this disease


Novel Covid-19 vaccine may protect the immunocompromised
Biotech | April 13, 2022

Novel Covid-19 vaccine may protect the immunocompromised

The peptide-based vaccine induces a t cell-dependent response